Endocrine cells in the ileum of patients with irritable bowel syndrome

World Journal of Gastroenterology

Volumn 20, Issue 9, 2014, Pages 2383-2391

  El Salhy, Magdy ^a,c   Gilja, Odd Helge ^c   Gundersen, Doris ^b   Hatlebakk, Jan Gunnar ^c   Hausken, Trygve ^c  

^a Stord Helse Fonna Hospital   (Norway)

^b Helse Fonna ^*  (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

Computer image analysis; Ileum; Irritable bowel syndrome; Peptide YY; Serotonin

Indexed keywords

NEUROGENIN 3; OXYNTOMODULIN; PANCREAS POLYPEPTIDE; PROSTAGLANDIN E2; SEROTONIN; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE; VASOACTIVE INTESTINAL POLYPEPTIDE; BIOLOGICAL MARKER; GLUCAGON LIKE PEPTIDE; PEPTIDE YY; SOMATOSTATIN;

ADULT; AGED; ANGIODYSPLASIA; ARTICLE; BIOPSY; CELL DENSITY; COLON CARCINOMA; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; ENTEROENDOCRINE CELL; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMORRHOID; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; SOMATOSTATIN CELL; ADOLESCENT; CASE CONTROL STUDY; CHEMISTRY; COLONOSCOPY; COMPLICATION; COMPUTER ASSISTED DIAGNOSIS; ENDOCRINE CELL; HYPERALGESIA; ILEUM; METABOLISM; MIDDLE AGED; PAIN MEASUREMENT; PATHOLOGY; VISCERAL PAIN; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; COLONOSCOPY; CONSTIPATION; DIARRHEA; ENDOCRINE CELLS; FEMALE; GLUCAGON-LIKE PEPTIDES; HUMANS; HYPERALGESIA; ILEUM; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PAIN MEASUREMENT; PANCREATIC POLYPEPTIDE; PEPTIDE YY; QUESTIONNAIRES; SEROTONIN; SOMATOSTATIN; SOMATOSTATIN-SECRETING CELLS; VISCERAL PAIN; YOUNG ADULT;

EID: 84895873859     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i9.2383     Document Type: Article

References (94)

1. Thompson WG. A world view of IBS. In: Camilleri M, Spiller RC, editors. Irritable bowel syndrome: diagnosis and treatment. Philadelphia and London: Saunders, 2002: 17-26
2. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38: 1569-1580 [PMID: 8359066 DOI: 10.1007/BF01303162]
3. El-Salhy M, Gundersen D, Hatlebakk JG, Hausken T. Irritable bowel syndrome: diagnosis, pathogenesis and treatment options. New York: Nova Science Publishers, Inc., 2012
4. Ford AC, Vandvik PO. Irritable bowel syndrome. Clin Evid (Online) 2012; 2012: pii: 0410 [PMID: 22296841]
5. Quigley EM, Locke GR, Mueller-Lissner S, Paulo LG, Tytgat GN, Helfrich I, Schaefer E. Prevalence and management of abdominal cramping and pain: a multinational survey. Aliment Pharmacol Ther 2006; 24: 411-419 [PMID: 16842469 DOI: 10.1111/j.1365-2036.2006.02989.x]
6. Vandvik PO, Lydersen S, Farup PG. Prevalence, comorbidity and impact of irritable bowel syndrome in Norway. Scand J Gastroenterol 2006; 41: 650-656 [PMID: 16716962 DOI: 10.1080/00365520500442542]
7. Saito YA, Schoenfeld P, Locke GR. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002; 97: 1910-1915 [PMID: 12190153 DOI: 10.1111/j.1572-0241.2002.05913.x]
8. Dakin CL, Small CJ, Batterham RL, Neary NM, Cohen MA, Patterson M, Ghatei MA, Bloom SR. Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology 2004; 145: 2687-2695 [PMID: 15001546 DOI: 10.1210/en.2003-1338]
9. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10: 712-721. e4 [PMID: 22426087 DOI: 10.1016/j.cgh.2012.02.029]
10. El-Salhy M, Gundersen D, Hatlebakk JG, Hausken T. Chromogranin A cell density as a diagnostic marker for lymphocytic colitis. Dig Dis Sci 2012; 57: 3154-3159 [PMID: 22699394 DOI: 10.1007/s10620-012-2249-6]
11. Harvey RF, Mauad EC, Brown AM. Prognosis in the irritable bowel syndrome: a 5-year prospective study. Lancet 1987; 1: 963-965 [PMID: 2882351]
12. Nørgaard M, Farkas DK, Pedersen L, Erichsen R, de la Cour ZD, Gregersen H, Sørensen HT. Irritable bowel syndrome and risk of colorectal cancer: a Danish nationwide cohort study. Br J Cancer 2011; 104: 1202-1206 [PMID: 21343936 DOI: 10.1038/bjc.2011.65]
13. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-1491 [PMID: 16678561 DOI: 10.1053/ j.gastro.2005.11.061]
14. Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, Jones R, Kumar D, Rubin G, Trudgill N, Whorwell P. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007; 56: 1770-1798 [PMID: 17488783 DOI: 10.1136/gut.2007.119446]
15. El-Salhy M. Irritable bowel syndrome: diagnosis and pathogenesis. World J Gastroenterol 2012; 18: 5151-5163 [PMID: 23066308 DOI: 10.3748/wjg.v18.i37.5151]
16. El-Salhy M, Lillebø E, Reinemo A, Salmelid L. Ghrelin in patients with irritable bowel syndrome. Int J Mol Med 2009; 23: 703-707 [PMID: 19424595]
17. Dizdar V, Spiller R, Singh G, Hanevik K, Gilja OH, El-Salhy M, Hausken T. Relative importance of abnormalities of CCK and 5-HT (serotonin) in Giardia-induced post-infectious irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2010; 31: 883-891 [PMID: 20132151 DOI: 10.1111/j.1365-2036.2010.04251.x]
18. El-Salhy M, Vaali K, Dizdar V, Hausken T. Abnormal smallintestinal endocrine cells in patients with irritable bowel syndrome. Dig Dis Sci 2010; 55: 3508-3513 [PMID: 20300845 DOI: 10.1007/s10620-010-1169-6]
19. El-Salhy M, Gundersen D, Ostgaard H, Lomholt-Beck B, Hatlebakk JG, Hausken T. Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome. Dig Dis Sci 2012; 57: 873-878 [PMID: 22057239 DOI: 10.1007/s10620-011-1948-8]
20. El-Salhy M, Mazzawi T, Gundersen D, Hatlebakk JG, Hausken T. Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report. BMC Res Notes 2013; 6: 391 [PMID: 24073715 DOI: 10.1186/1756-0500-6-391]
21. Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, Crowell MD, Sharkey KA, Gershon MD, Mawe GM, Moses PL. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004; 126: 1657-1664 [PMID: 15188158 DOI: 10.1053/ j.gastro.2004.03.013]
22. Wang SH, Dong L, Luo JY, Gong J, Li L, Lu XL, Han SP. Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome. World J Gastroenterol 2007; 13: 6041-6047 [PMID: 18023097 DOI: 10.3748/wjg.13.6041]
23. Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK, Cho SW. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol 2008; 23: 1689-1694 [PMID: 19120860 DOI: 10.1111/ j.1440-1746.2008.05574.x]
24. Park JH, Rhee PL, Kim G, Lee JH, Kim YH, Kim JJ, Rhee JC, Song SY. Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoeapredominant irritable bowel syndrome. Neurogastroenterol Motil 2006; 18: 539-546 [PMID: 16771769 DOI: 10.1111/ j.1365-2982.2006.00771.x]
25. Kim HS, Lim JH, Park H, Lee SI. Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection--an observation in a small case control study. Yonsei Med J 2010; 51: 45-51 [PMID: 20046513 DOI: 10.3349/ ymj.2010.51.1.45]
26. Dunlop SP, Coleman NS, Blackshaw E, Perkins AC, Singh G, Marsden CA, Spiller RC. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol 2005; 3: 349-357 [PMID: 15822040 DOI: 10.1016/S1542-3565(04)00726-8]
27. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, Neal KR. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000; 47: 804-811 [PMID: 11076879 DOI: 10.1136/gut.47.6.804]
28. El-Salhy M, Lomholt-Beck B, Hausken T. Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome. Scand J Gastroenterol 2010; 45: 1435-1439 [PMID: 20602602 DOI: 10.3109/00365521.2010.503965]
29. El-Salhy M, Mazzawi T, Gundersen D, Hausken T. Chromogranin A cell density in the rectum of patients with irritable bowel syndrome. Mol Med Rep 2012; 6: 1223-1225 [PMID: 22992886 DOI: 10.3892/mmr.2012.1087]
30. El-Salhy M, Seim I, Chopin L, Gundersen D, Hatlebakk JG, Hausken T. Irritable bowel syndrome: the role of gut neuroendocrine peptides. Front Biosci (Elite Ed) 2012; 4: 2783-2800 [PMID: 22652678]
31. El-Salhy M, Wendelbo IH, Gundersen D. Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome. Mol Med Rep 2013; 7: 1241-1244 [PMID: 23426642 DOI: 10.3892/mmr.2013.1325]
32. Taupenot L, Harper KL, O'Connor DT. The chromograninsecretogranin family. N Engl J Med 2003; 348: 1134-1149 [PMID: 12646671 DOI: 10.1056/NEJMra021405]
33. Wiedenmann B, Huttner WB. Synaptophysin and chromogranins/ secretogranins--widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis. Virchows Arch B Cell Pathol Incl Mol Pathol 1989; 58: 95-121 [PMID: 2575822 DOI: 10.1007/BF02890062]
34. Deftos LJ. Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endocr Rev 1991; 12: 181-187 [PMID: 2070778 DOI: 10.1210/ edrv-12-2-181]
35. Roalfe AK, Roberts LM, Wilson S. Evaluation of the Birmingham IBS symptom questionnaire. BMC Gastroenterol 2008; 8: 30 [PMID: 18651941 DOI: 10.1186/1471-230x-8-30]
36. el-Salhy M, Sandström O, Näsström E, Mustajbasic M, Zachrisson S. Application of computer image analysis in endocrine cell quantification. Histochem J 1997; 29: 249-256 [PMID: 9472387]
37. El-Salhy M, Gundersen D, Hatlebakk JG, Hausken T. High densities of serotonin and peptide YY cells in the colon of patients with lymphocytic colitis. World J Gastroenterol 2012; 18: 6070-6075 [PMID: 23155335 DOI: 10.3748/wjg.v18.i42.6070]
38. El-Salhy M, Gundersen D, Hatlebakk JG, Hausken T. Abnormal rectal endocrine cells in patients with irritable bowel syndrome. Regul Pept 2013; 188C: 60-65 [PMID: 24316398]
39. Wang LH, Fang XC, Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 2004; 53: 1096-1101 [PMID: 15247174 DOI: 10.1136/ gut.2003.021154]
40. Dunlop SP, Jenkins D, Neal KR, Spiller RC. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003; 125: 1651-1659 [PMID: 14724817]
41. Cardoso WV, Lü J. Regulation of early lung morphogenesis: questions, facts and controversies. Development 2006; 133: 1611-1624 [PMID: 16613830 DOI: 10.1242/dev.02310]
42. Darlington GJ. Molecular mechanisms of liver development and differentiation. Curr Opin Cell Biol 1999; 11: 678-682 [PMID: 10600708]
43. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006; 43: S45-S53 [PMID: 16447274 DOI: 10.1002/ hep.20969]
44. Rawlins EL, Hogan BL. Ciliated epithelial cell lifespan in the mouse trachea and lung. Am J Physiol Lung Cell Mol Physiol 2008; 295: L231-L234 [PMID: 18487354 DOI: 10.1152/ajplung. 90209.2008]
45. Zaret KS. Regulatory phases of early liver development: paradigms of organogenesis. Nat Rev Genet 2002; 3: 499-512 [PMID: 12094228 DOI: 10.1038/nrg837]
46. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ, Clevers H. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007; 449: 1003-1007 [PMID: 17934449 DOI: 10.1038/nature06196]
47. Barker N, van de Wetering M, Clevers H. The intestinal stem cell. Genes Dev 2008; 22: 1856-1864 [PMID: 18628392 DOI: 10.1101/gad.1674008]
48. Barker N, Clevers H. Tracking down the stem cells of the intestine: strategies to identify adult stem cells. Gastroenterology 2007; 133: 1755-1760 [PMID: 18054544 DOI: 10.1053/ j.gastro.2007.10.029]
49. Cheng H, Leblond CP. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. Am J Anat 1974; 141: 537-561 [PMID: 4440635 DOI: 10.1002/aja.1001410407]
50. Fontaine J, Le Lièvre C, Le Douarin NM. What is the developmental fate of the neural crest cells which migrate into the pancreas in the avian embryo? Gen Comp Endocrinol 1977; 33: 394-404 [PMID: 924129 DOI: 10.1016/0016-6480(77)90055-7]
51. Le Douarin NM, Teillet MA. The migration of neural crest cells to the wall of the digestive tract in avian embryo. J Embryol Exp Morphol 1973; 30: 31-48 [PMID: 4729950]
52. Rawdon BB, Andrew A. Origin and differentiation of gut endocrine cells. Histol Histopathol 1993; 8: 567-580 [PMID: 8358166]
53. Hoffman J, Kuhnert F, Davis CR, Kuo CJ. Wnts as essential growth factors for the adult small intestine and colon. Cell Cycle 2004; 3: 554-557 [PMID: 15044853 DOI: 10.4161/ cc.3.5.858]
54. Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ, Clevers H. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 1998; 19: 379-383 [PMID: 9697701 DOI: 10.1038/1270]
55. May CL, Kaestner KH. Gut endocrine cell development. Mol Cell Endocrinol 2010; 323: 70-75 [PMID: 20025933 DOI: 10.1016/j.mce.2009.12.009]
56. Gunawardene AR, Corfe BM, Staton CA. Classification and functions of enteroendocrine cells of the lower gastrointestinal tract. Int J Exp Pathol 2011; 92: 219-231 [PMID: 21518048 DOI: 10.1111/j.1365-2613.2011.00767.x]
57. Lee CS, Kaestner KH. Clinical endocrinology and metabolism. Development of gut endocrine cells. Best Pract Res Clin Endocrinol Metab 2004; 18: 453-462 [PMID: 15533769 DOI: 10.1016/j.beem.2004.08.008]
58. Fishbein TM, Novitskiy G, Lough DM, Matsumoto C, Kaufman SS, Shetty K, Zasloff M. Rejection reversibly alters enteroendocrine cell renewal in the transplanted small intestine. Am J Transplant 2009; 9: 1620-1628 [PMID: 19519821 DOI: 10.1111/j.1600-6143.2009.02681.x]
59. Wang J, Cortina G, Wu SV, Tran R, Cho JH, Tsai MJ, Bailey TJ, Jamrich M, Ament ME, Treem WR, Hill ID, Vargas JH, Gershman G, Farmer DG, Reyen L, Martín MG. Mutant neurogenin-3 in congenital malabsorptive diarrhea. N Engl J Med 2006; 355: 270-280 [PMID: 16855267 DOI: 10.1056/NEJMoa054288]
60. Gershon MD. Plasticity in serotonin control mechanisms in the gut. Curr Opin Pharmacol 2003; 3: 600-607 [PMID: 14644011 DOI: 10.1016/j.coph.2003.07.005]
61. Kellum JM, Albuquerque FC, Stoner MC, Harris RP. Stroking human jejunal mucosa induces 5-HT release and Clsecretion via afferent neurons and 5-HT4 receptors. Am J Physiol 1999; 277: G515-G520 [PMID: 10484375]
62. Camilleri M. Serotonergic modulation of visceral sensation: lower gut. Gut 2002; 51 Suppl 1: i81-i86 [PMID: 12077074 DOI: 10.1136/gut.51.suppl_1.i81]
63. Tack J, Sarnelli G. Serotonergic modulation of visceral sensation: upper gastrointestinal tract. Gut 2002; 51 Suppl 1: i77-i80 [PMID: 12077073 DOI: 10.1136/gut.51.suppl_1.i77]
64. Kerckhoffs AP, ter Linde JJ, Akkermans LM, Samsom M. SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine. Am J Physiol Gastrointest Liver Physiol 2012; 302: G1053-G1060 [PMID: 22323131 DOI: 10.1152/ajpgi. 00153.2011]
65. Maljaars PW, Keszthelyi D, Masclee AA. An ileal brakethrough? Am J Clin Nutr 2010; 92: 467-468 [PMID: 20685954 DOI: 10.3945/ajcn.2010.30180]
66. Van Citters GW, Lin HC. Ileal brake: neuropeptidergic control of intestinal transit. Curr Gastroenterol Rep 2006; 8: 367-373 [PMID: 16968603 DOI: 10.1007/s11894-006-0021-9]
67. Lin HC, Zhao XT, Wang L, Wong H. Fat-induced ileal brake in the dog depends on peptide YY. Gastroenterology 1996; 110: 1491-1495 [PMID: 8613054 DOI: 10.1053/gast.1996.v110. pm8613054]
68. Pironi L, Stanghellini V, Miglioli M, Corinaldesi R, De Giorgio R, Ruggeri E, Tosetti C, Poggioli G, Morselli Labate AM, Monetti N. Fat-induced ileal brake in humans: a dose-dependent phenomenon correlated to the plasma levels of peptide YY. Gastroenterology 1993; 105: 733-739 [PMID: 8359644]
69. Spiller RC, Trotman IF, Adrian TE, Bloom SR, Misiewicz JJ, Silk DB. Further characterisation of the 'ileal brake' reflex in man--effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY. Gut 1988; 29: 1042-1051 [PMID: 3410330 DOI: 10.1136/gut.29.8.1042]
70. Spiller RC, Trotman IF, Higgins BE, Ghatei MA, Grimble GK, Lee YC, Bloom SR, Misiewicz JJ, Silk DB. The ileal brake--inhibition of jejunal motility after ileal fat perfusion in man. Gut 1984; 25: 365-374 [PMID: 6706215 DOI: 10.1136/ gut.25.4.365]
71. Goumain M, Voisin T, Lorinet AM, Ducroc R, Tsocas A, Rozé C, Rouet-Benzineb P, Herzog H, Balasubramaniam A, Laburthe M. The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y(2) receptor: pharmacological evidence and molecular cloning. Mol Pharmacol 2001; 60: 124-134 [PMID: 11408607]
72. Souli A, Chariot J, Voisin T, Presset O, Tsocas A, Balasubramaniam A, Laburthe M, Rozé C. Several receptors mediate the antisecretory effect of peptide YY, neuropeptide Y, and pancreatic polypeptide on VIP-induced fluid secretion in the rat jejunum in vivo. Peptides 1997; 18: 551-557 [PMID: 9210175 DOI: 10.1016/S0196-9781(97)00069-7]
73. Whang EE, Hines OJ, Reeve JR, Grandt D, Moser JA, Bilchik AJ, Zinner MJ, McFadden DW, Ashley SW. Antisecretory mechanisms of peptide YY in rat distal colon. Dig Dis Sci 1997; 42: 1121-1127 [PMID: 9201071 DOI: 10.1023/ A:1018869116284]
74. Moriya R, Shirakura T, Hirose H, Kanno T, Suzuki J, Kanatani A. NPY Y2 receptor agonist PYY(3-36) inhibits diarrhea by reducing intestinal fluid secretion and slowing colonic transit in mice. Peptides 2010; 31: 671-675 [PMID: 19925840 DOI: 10.1016/j.peptides.2009.11.005]
75. Hataya Y, Akamizu T, Takaya K, Kanamoto N, Ariyasu H, Saijo M, Moriyama K, Shimatsu A, Kojima M, Kangawa K, Nakao K. A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 2001; 86: 4552 [PMID: 11549707 DOI: 10.1210/jc.86.9.4552]
76. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86: 5992 [PMID: 11739476 DOI: 10.1210/ jc.86.12.5992]
77. Hosoda H, Kojima M, Kangawa K. Ghrelin and the regulation of food intake and energy balance. Mol Interv 2002; 2: 494-503 [PMID: 14993401 DOI: 10.1124/mi.2.8.494]
78. Masuda Y, Tanaka T, Inomata N, Ohnuma N, Tanaka S, Itoh Z, Hosoda H, Kojima M, Kangawa K. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 2000; 276: 905-908 [PMID: 11027567 DOI: 10.1006/ bbrc.2000.3568]
79. Fujino K, Inui A, Asakawa A, Kihara N, Fujimura M, Fujimiya M. Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol 2003; 550: 227-240 [PMID: 12837928 DOI: 10.1113/jphysiol.2003.040600]
80. Dornonville de la Cour C, Lindström E, Norlén P, Håkanson R. Ghrelin stimulates gastric emptying but is without effect on acid secretion and gastric endocrine cells. Regul Pept 2004; 120: 23-32 [PMID: 15177917 DOI: 10.1016/j.regpep.2004.02.008]
81. Fukuda H, Mizuta Y, Isomoto H, Takeshima F, Ohnita K, Ohba K, Omagari K, Taniyama K, Kohno S. Ghrelin enhances gastric motility through direct stimulation of intrinsic neural pathways and capsaicin-sensitive afferent neurones in rats. Scand J Gastroenterol 2004; 39: 1209-1214 [PMID: 15742997]
82. Edholm T, Levin F, Hellström PM, Schmidt PT. Ghrelin stimulates motility in the small intestine of rats through intrinsic cholinergic neurons. Regul Pept 2004; 121: 25-30 [PMID: 15256270 DOI: 10.1016/j.regpep.2004.04.001]
83. Levin F, Edholm T, Schmidt PT, Grybäck P, Jacobsson H, Degerblad M, Höybye C, Holst JJ, Rehfeld JF, Hellström PM, Näslund E. Ghrelin stimulates gastric emptying and hunger in normal-weight humans. J Clin Endocrinol Metab 2006; 91: 3296-3302 [PMID: 16772353 DOI: 10.1210/jc.2005-2638]
84. Tack J, Depoortere I, Bisschops R, Delporte C, Coulie B, Meulemans A, Janssens J, Peeters T. Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut 2006; 55: 327-333 [PMID: 16216827 DOI: 10.1136/gut.2004.060426]
85. Ariga H, Nakade Y, Tsukamoto K, Imai K, Chen C, Mantyh C, Pappas TN, Takahashi T. Ghrelin accelerates gastric emptying via early manifestation of antro-pyloric coordination in conscious rats. Regul Pept 2008; 146: 112-116 [PMID: 17913258 DOI: 10.1016/j.regpep.2007.08.022]
86. Ariga H, Tsukamoto K, Chen C, Mantyh C, Pappas TN, Takahashi T. Endogenous acyl ghrelin is involved in mediating spontaneous phase III-like contractions of the rat stomach. Neurogastroenterol Motil 2007; 19: 675-680 [PMID: 17640183 DOI: 10.1111/j.1365-2982.2007.00945.x]
87. Tümer C, Oflazoǧlu HD, Obay BD, Kelle M, Taşdemir E. Effect of ghrelin on gastric myoelectric activity and gastric emptying in rats. Regul Pept 2008; 146: 26-32 [PMID: 17825442 DOI: 10.1016/j.regpep.2007.07.008]
88. Tebbe JJ, Mronga S, Tebbe CG, Ortmann E, Arnold R, Schäfer MK. Ghrelin-induced stimulation of colonic propulsion is dependent on hypothalamic neuropeptide Y1-and corticotrophin-releasing factor 1 receptor activation. J Neuroendocrinol 2005; 17: 570-576 [PMID: 16101895 DOI: 10.1111/ j.1365-2826.2005.01340.x]
89. Goyal RK, Hirano I. The enteric nervous system. N Engl J Med 1996; 334: 1106-1115 [PMID: 8598871 DOI: 10.1056/ nejm199604253341707]
90. El-Salhy M, Mazzawi T, Gundersen D, Hatlebakk JG, Hausken T. The role of peptide YY in gastrointestinal diseases and disorders (review). Int J Mol Med 2013; 31: 275-282 [PMID: 23292145 DOI: 10.3892/ijmm.2012.1222]
91. Camilleri M. Integrated upper gastrointestinal response to food intake. Gastroenterology 2006; 131: 640-658 [PMID: 16890616 DOI: 10.1053/j.gastro.2006.03.023]
92. Lal S, McLaughlin J, Barlow J, D'Amato M, Giacovelli G, Varro A, Dockray GJ, Thompson DG. Cholecystokinin pathways modulate sensations induced by gastric distension in humans. Am J Physiol Gastrointest Liver Physiol 2004; 287: G72-G79 [PMID: 14764444 DOI: 10.1152/ajpgi.00351.2003]
93. Moran TH, Ladenheim EE, Schwartz GJ. Within-meal gut feedback signaling. Int J Obes Relat Metab Disord 2001; 25 Suppl 5: S39-S41 [PMID: 11840213 DOI: 10.1038/sj.ijo.0801910]
94. Smith GP, Falasco J, Moran TH, Joyner KM, Gibbs J. CCK-8 decreases food intake and gastric emptying after pylorectomy or pyloroplasty. Am J Physiol 1988; 255: R113-R116 [PMID: 3394832]